Application 218091
- Type
- ANDA
- Sponsor
- SINOTHERAPEUTICS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | DAPAGLIFLOZIN AND METFORMIN | DAPAGLIFLOZIN || METFORMIN | TABLET | 5MG | No | No |
| 003 | DAPAGLIFLOZIN AND METFORMIN | DAPAGLIFLOZIN || METFORMIN | TABLET | 10MG | No | No |
| 004 | DAPAGLIFLOZIN AND METFORMIN | DAPAGLIFLOZIN || METFORMIN | TABLET | 500MG | No | No |
| 005 | DAPAGLIFLOZIN AND METFORMIN | DAPAGLIFLOZIN || METFORMIN | TABLET | 1000MG | No | No |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.